Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease through percutaneous cardiovascular interventions.
Improving the quality of life and reducing sudden cardiac death by limiting the impact of heart rhythm disturbances.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Dr. Ruxandra Jurcut,
A pregnant women and fetus or lactating mother and baby in general are at increased risk of being impacted by disease and the effects of medication. Specifically, presence of thromboembolic disease and/or specific thrombophilia (i.e. antiphospholipid syndrome) or a mechanical prosthesis may warrant the use of anticoagulation. Definite knowledge of anticoagulation in these situations is warranted.
Interesting link: ESC guidelines on cardiovascular diseases during pregnancy.
1)Venous Thromboembolism in Pregnancy. James HA. Arterioscler Thromb Vasc Biol 2009; 29;326-3312)Pregnancy-related mortality in the United States, 1998 to 2005. Berg CJ, Callaghan WM, Syverson C, Henderson Z. Obstet Gynecol. 2010 Dec;116(6):1302-93)Anticoagulants and pregnancy: When are they safe?Gibson PS, Powrie R. Cleve Clin J Med. 2009;76(2):113-274)Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (9th edition).Bates S, Greer I, Middeldorp D et al. Chest. 2012; 141(2)(Suppl):e691S–e736S5)ESC Guidelines on the management of cardiovascular diseases during pregnancy.Regitz-Zagrosek V, Blomstrom Lundqvist V, Borghi C et al. Eur Heart J. 2011;32(24):3147-97
Ruxandra Jurcut MD, PhD, FESCUniversity of Medicine and Pharmacy “Carol Davila” – Department of CardiologyInstitute of Emergency for Cardiovascular Diseases “Prof.dr.C.C.Iliescu”Bucharest, RomaniaAuthor's disclosures: none declared.
© 2017 European Society of Cardiology. All rights reserved